AnalystsPaul KnightPaul Knight's Stock Forecasts
AnalystsPaul Knight
Analyst Ranking
Top 10%
#354 out of 3582 analysts
Average Return
+14.61%
Win Rate
50%27 out of 54
Risk vs Reward
Poor
Good
Paul Knight's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Avid Bioservices IncCDMO | +303.75% | $8.26 | $33.35 | 2020-11-09 - 2021-11-09 | Strong Buy |
Cryoport IncCYRX | +186.11% | $5.47 | $15.65 | 2017-07-11 - 2018-07-12 | Strong Buy |
Oncocyte CorpOCX | +110.59% | $1.70 | $3.58 | 2020-11-09 - 2021-11-09 | Strong Buy |
Azenta IncAZTA | +107.18% | $59.43 | $123.13 | 2020-11-09 - 2021-11-09 | Strong Buy |
Harvard Bioscience IncHBIO | +95.38% | $3.90 | $7.62 | 2020-11-09 - 2021-11-09 | Strong Buy |
Paul Knight's Stock Coverage
| Name / Ticker | # of Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Avid Bioservices IncCDMO | 3 | Hold | N/A | N/A | Downgrades | 2 months ago |
Azenta IncAZTA | 6 | Strong Buy | $132.00 | +61.63% | Maintains | 2 months ago |
Exagen IncXGN | 3 | Strong Buy | $30.00 | +239.37% | Maintains | 2 months ago |
Cryoport IncCYRX | 3 | Strong Buy | $92.00 | +107.21% | Maintains | 3 months ago |
Danaher CorpDHR | 3 | Strong Buy | $345.00 | +24.61% | Maintains | 3 months ago |
Thermo Fisher Scientific IncTMO | 4 | Strong Buy | $710.00 | +23.31% | Maintains | 4 months ago |
Repligen CorpRGEN | 2 | Strong Buy | $335.00 | +76.51% | Maintains | 4 months ago |
BIO-TECHNE CorpTECH | 2 | Strong Buy | $600.00 | +57.11% | Upgrades | 4 months ago |
Avantor IncAVTR | 4 | Strong Buy | $51.00 | +39.46% | Maintains | 5 months ago |
Catalent IncCTLT | 2 | Strong Buy | $155.00 | +49.41% | Maintains | 5 months ago |
Agilent Technologies IncA | 4 | Strong Buy | $195.00 | +41.18% | Maintains | 5 months ago |
Biolife Solutions IncBLFS | 2 | Strong Buy | $60.00 | +106.11% | Maintains | 5 months ago |
Maravai Lifesciences Holdings IncMRVI | 4 | Strong Buy | $58.00 | +116.82% | Maintains | 5 months ago |
Stevanato Group SpASTVN | 1 | Strong Buy | $27.00 | +45.01% | Initiates Coverage On | 5 months ago |
West Pharmaceutical Services IncWST | 2 | Strong Buy | $475.00 | +23.85% | Maintains | 6 months ago |
Codex DNA IncDNAY | 1 | Strong Buy | $30.00 | +331.65% | Initiates Coverage On | 6 months ago |
Berkeley Lights IncBLI | 2 | Hold | N/A | N/A | Downgrades | 7 months ago |
Castle Biosciences IncCSTL | 2 | Strong Buy | $90.00 | +153.95% | Maintains | a year ago |
Teleflex IncTFX | 1 | Strong Buy | $441.00 | N/A | Maintains | a year ago |
Icu Medical IncICUI | 1 | Strong Buy | $236.00 | N/A | Maintains | a year ago |
Cooper Companies IncCOO | 1 | Strong Buy | $396.00 | N/A | Maintains | a year ago |
Avanos Medical IncAVNS | 1 | Strong Buy | $55.00 | N/A | Maintains | a year ago |
Waters CorpWAT | 3 | Hold | N/A | N/A | Initiates Coverage On | a year ago |
Veracyte IncVCYT | 3 | Hold | N/A | N/A | Initiates Coverage On | a year ago |
Perkinelmer IncPKI | 3 | Hold | N/A | N/A | Initiates Coverage On | a year ago |
Oncocyte CorpOCX | 1 | Strong Buy | $5.00 | N/A | Initiates Coverage On | a year ago |
Mesa Laboratories IncMLAB | 1 | Hold | N/A | N/A | Initiates Coverage On | a year ago |
Harvard Bioscience IncHBIO | 1 | Strong Buy | $6.00 | N/A | Initiates Coverage On | a year ago |
Interpace Biosciences IncIDXG | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 2 years ago |
Illumina IncILMN | 1 | Hold | N/A | N/A | Upgrades | 4 years ago |
NanoString Technologies IncNSTG | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Foundation Medicine IncFMI | 1 | Hold | N/A | N/A | Upgrades | 5 years ago |
©2022 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.